Gynaecological Cancers Risk Breast Cancer, Ovarian Cancer and Endometrial Cancer

• Eará dahkkit: Manchanda, Ranjit (Doaimmaheaddji)
• Materiálatiipa: Elektrovnnalaš Girjji oassi
• Giella: eaŋgalasgiella
• Almmustuhtton: Basel MDPI - Multidisciplinary Digital Publishing Institute 2022
• Fáttát: Public health & preventive medicine; breast cancer; galectins; galectin-7; galectin-8; prognostic markers; tumor infiltrating macrophages; screening; mammography; incidence-based mortality; population genetic testing; ovarian cancer risk; risk stratification; BRCA1; BRCA2; RAD51C; RAD51D; BRIP1; SNP; risk modelling; BRCA; population testing; cost-effectiveness; ovarian cancer; cancer prevention; CA125; HE4; UKCTOCS; MMT; postmenopausal women; rare germline variants; susceptibility genes; genomics; questionnaires; attitudes; symptoms; early detection; risk assessment; diagnostic prediction model; triage tool; ovarian cancer symptoms; family history; risk; genes; prevention; dyskerin; DKC1; endometrial cancer; telomerase; proliferation; telomeres; obesity; metabolomics; liquid biopsy; mass spectrometry; plasma biomarkers; artificial intelligence; ultrasound; TVS; trial; randomised controlled trial; genomic sequencing; tumor mutational signatures; hereditary cancer genes; mismatch repair; familial cancer; menopausal hormone therapy; breast cancer risk; BMI; early BMI; age of pregnancy; mammographic density; body mass index; weight loss; breast cancer prevention; premenopausal; genetic testing; germline; somatic; n/a
• Liŋkkat: DOAB: download the publication; DOAB: description of the publication

The International Agency for Research on Cancer suggests that the burden of women's cancers including breast, ovarian, and womb will rise by 50% over the next 20 years. It is essential for us to improve early diagnosis and prevention of these cancers in our health systems. The last decade has s...